These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 3002926

  • 1. [Correlation between the inhibition of renin-angiotensin system and antihypertensive effect of MK-421 and captopril in 2-kidney, 1-clip renal hypertensive rats after single and repeated oral administration of MK-421 or captopril].
    Ohmura I, Maki E, Naruse T, Ikeda N, Asami T, Sagawa N.
    Nihon Yakurigaku Zasshi; 1985 Oct; 86(4):303-13. PubMed ID: 3002926
    [Abstract] [Full Text] [Related]

  • 2. [Effects of single and repeated oral administration of MK-421 and captopril on blood pressures in normotensive and experimental hypertensive rats].
    Ohmura I, Maki E, Naruse T, Chen CS, Ikeda N, Asami T.
    Nihon Yakurigaku Zasshi; 1985 Oct; 86(4):293-302. PubMed ID: 3002925
    [Abstract] [Full Text] [Related]

  • 3. [Angiotensin converting enzyme inhibitory activity of MK-0521 in vivo and antihypertensive effect of its single oral administration on blood pressure and effect on the renin-angiotensin system in 2-kidney Goldblatt hypertensive dogs].
    Oda M, Ino Y, Suzuki K, Sato T, Iwamoto S, Iwaki M.
    Nihon Yakurigaku Zasshi; 1989 Apr; 93(4):225-34. PubMed ID: 2545579
    [Abstract] [Full Text] [Related]

  • 4. Relationship between angiotensin I blockade and antihypertensive properties of single doses of MK-421 and captopril in spontaneous and renal hypertensive rats.
    Sweet CS, Arbegast PT, Gaul SL, Blaine EH, Gross DM.
    Eur J Pharmacol; 1981 Dec 03; 76(2-3):167-76. PubMed ID: 6174351
    [Abstract] [Full Text] [Related]

  • 5. Effects of an angiotensin-converting enzyme (ACE) inhibitor, SA446, on tissue ACE activity in normotensive, spontaneously hypertensive, and renal hypertensive rats.
    Nakata K, Nishimura K, Takada T, Ikuse T, Yamauchi H, Iso T.
    J Cardiovasc Pharmacol; 1987 Mar 03; 9(3):305-10. PubMed ID: 2437397
    [Abstract] [Full Text] [Related]

  • 6. Hypotensive effect of SA446, an angiotensin converting enzyme inhibitor, in 2-kidney, 1-clip renal hypertensive and normotensive dogs.
    Nishimura K, Miyazaki M, Okunishi H, Toda N.
    Jpn J Pharmacol; 1987 Apr 03; 43(4):379-87. PubMed ID: 3039218
    [Abstract] [Full Text] [Related]

  • 7. Antihypertensive activity of alacepril, an orally active angiotensin converting enzyme inhibitor, in renal hypertensive rats and dogs.
    Takeyama K, Minato H, Fukuya F, Kawahara S, Hosoki K, Kadokawa T.
    Arzneimittelforschung; 1985 Apr 03; 35(10):1502-7. PubMed ID: 3000389
    [Abstract] [Full Text] [Related]

  • 8. Differential effects of captopril and enalapril on tissue renin-angiotensin systems in experimental heart failure.
    Hirsch AT, Talsness CE, Smith AD, Schunkert H, Ingelfinger JR, Dzau VJ.
    Circulation; 1992 Nov 03; 86(5):1566-74. PubMed ID: 1330361
    [Abstract] [Full Text] [Related]

  • 9. Tissue levels, tissue angiotensin converting enzyme inhibition and antihypertensive effect of the novel antihypertensive agent alacepril in renal hypertensive rats.
    Nambu K, Matsumoto K, Takeyama K, Hosoki K, Miyazaki H, Hashimoto M.
    Arzneimittelforschung; 1986 Nov 03; 36(1):47-51. PubMed ID: 3006710
    [Abstract] [Full Text] [Related]

  • 10. [Antihypertensive effect of repeated oral administration of MK-0521 in 2-kidney Goldblatt hypertensive dogs].
    Oda M, Suzuki K, Ino Y, Sato T, Iwaki M.
    Nihon Yakurigaku Zasshi; 1989 Apr 03; 93(4):235-43. PubMed ID: 2545580
    [Abstract] [Full Text] [Related]

  • 11. Effects of chronic converting enzyme inhibition on the vascular renin-angiotensin system.
    Saito H, Nakamaru M, Rakugi H, Mikami H, Ogihara T, Inagami T.
    Clin Exp Pharmacol Physiol; 1990 Nov 03; 17(11):745-53. PubMed ID: 2150362
    [Abstract] [Full Text] [Related]

  • 12. Acute antihypertensive synergism of angiotensin-converting enzyme inhibitors and diuretics.
    Chan PS, Ronsberg MA, Cervoni P.
    Fed Proc; 1984 Apr 03; 43(5):1346-50. PubMed ID: 6200364
    [Abstract] [Full Text] [Related]

  • 13. Antihypertensive activity of captopril (SQ 14,225), an orally active inhibitor of angiotensin converting enzyme in conscious two-kidney perinephritic hypertensive dogs.
    Vollmer RR, Boccagno JA, Steinbacher TE, Horovitz ZP, Murthy VS.
    J Pharmacol Exp Ther; 1981 Feb 03; 216(2):225-31. PubMed ID: 6257882
    [Abstract] [Full Text] [Related]

  • 14. Angiotensin-converting enzyme inhibition with quinapril (CI-906) and captopril in spontaneously hypertensive rats with suppressed renin-angiotensin system.
    Säynävälammi P, Pörsti I.
    Methods Find Exp Clin Pharmacol; 1987 Jun 03; 9(6):325-31. PubMed ID: 3309510
    [Abstract] [Full Text] [Related]

  • 15. Antihypertensive action of a new angiotensin converting enzyme inhibitor, (R)-3-[(S)-1-carboxy-5-(4-piperidyl)pentyl]amino-4-oxo-2,3,4,5-tetr ahy dro-1,5-benzothiazepine-5-acetic acid (CV-5975), in various hypertensive models.
    Inada Y, Tanabe M, Kawazoe K, Nishikawa K.
    Jpn J Pharmacol; 1988 Jul 03; 47(3):311-22. PubMed ID: 2851677
    [Abstract] [Full Text] [Related]

  • 16. Role of the tissue renin-angiotensin system in the action of angiotensin-converting enzyme inhibitors.
    Tokita Y, Oda H, Franco-Saenz R, Mulrow PJ.
    Proc Soc Exp Biol Med; 1995 Apr 03; 208(4):391-6. PubMed ID: 7700888
    [Abstract] [Full Text] [Related]

  • 17. Pharmacological properties of the converting enzyme inhibitor, enalapril maleate (MK-421).
    Sweet CS.
    Fed Proc; 1983 Feb 03; 42(2):167-70. PubMed ID: 6295819
    [Abstract] [Full Text] [Related]

  • 18. Should the use of short acting angiotensin-converting enzyme inhibitors be abandoned?
    Erman A, Boner G, van Dijk DJ.
    J Renin Angiotensin Aldosterone Syst; 2000 Dec 03; 1(4):365-8. PubMed ID: 11967825
    [Abstract] [Full Text] [Related]

  • 19. Comparative effects of enalapril, enalaprilic acid and captopril in blocking angiotensin I-induced pressor and dipsogenic responses in spontaneously hypertensive rats.
    Gaul SL, Martin GE, Sweet CS.
    Clin Exp Hypertens A; 1984 Dec 03; 6(6):1187-206. PubMed ID: 6086183
    [Abstract] [Full Text] [Related]

  • 20. Reversal of cardiac hypertrophy and fibrosis by S21402, a dual inhibitor of neutral endopeptidase and angiotensin converting enzyme in SHRs.
    Farina NK, Johnston CI, Burrell LM.
    J Hypertens; 2000 Jun 03; 18(6):749-55. PubMed ID: 10872560
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.